Phenylpropanolamine and associated myocardial injury.
We report the cases of two patients without significant past medical history in whom developed myocardial injury attributed to the use of anorectic agents containing phenylpropanolamine. The pharmacologic properties of phenylpropanolamine and the current management of common adverse reactions to phenylpropanolamine are briefly reviewed.
Leo
P J
PJ
Department of Emergency Medicine, New York Methodist Hospital, Brooklyn, USA.
Hollander
J E
JE
Shih
R D
RD
Marcus
S M
SM
D000293:Adolescent; D000328:Adult; D001067:Appetite Depressants / Q000009:adverse effects*; D004562:Electrocardiography; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000139:chemically induced*; D010665:Phenylpropanolamine / Q000009:adverse effects*; D013566:Sympathomimetics / Q000009:adverse effects*
D001067:Appetite Depressants; D013566:Sympathomimetics; D010665:Phenylpropanolamine